By Sriparna Roy and Abigail Summerville (Reuters) -Band-Aid and Tylenol maker Kenvue has fired its CEO Thibaut Mongon, the ...

The Johnson & Johnson spinoff that makes Tylenol and Benadryl, said Chief Executive Thibaut Mongon has departed and that the ...

Kenvue’s board of directors are considering ‘a broad range of potential alternatives’ and are hunting for a permanent ...

Kenvue says that Thibaut Mongon is leaving as CEO as the maker of Listerine and Band-Aid brands continues with a strategic ...

Kenvue appoints Kirk Perry as interim CEO after Thibaut Mongon's exit and launches strategic review to simplify operations.

Kenvue (KVUE), the company behind Tylenol and Neutrogena, announced that Thibaut Mongon had left the company, naming Kirk ...

Perry is a current Kenvue director and seasoned consumer products and brand strategist with more than 30 years of experience.

The consumer health company also disclosed its CEO’s departure, following its CFO replacement earlier this year, and appointed an interim chief executive. Preliminary second-quarter 2025 results show ...

“The Board’s strategic review is underway, and we are considering a broad range of potential alternatives, including ways to ...

Kenvue, formerly part of Johnson & Johnson, announces CEO Thibaut Mongon's departure as it undergoes a strategic review.

All that culminated on Monday with the abrupt resignation of Kenvue CEO Thibaut Mongon, his replacement by board director ...

Kenvue CEO Thibaut Mongon has stepped down as the company’s chief executive and departed its board of directors. The CEO of Tylenol maker Kenvue ( KVUE) has left the company as part of an internal ...